Global Oncolytic Virus Therapy Market By Type (Newcastle Disease Virus-Based Oncolytic Viruses, Vaccinia Virus-Based Oncolytic Viruses, Vesicular Stomatitis Virus-Based Oncolytic Viruses, Adenoviruses-Based Oncolytic Viruses, HSV-Based Oncolytic Viruses), By Application (Breast Cancer, Ovarian Cancer, Melanoma, Prostate Cancer, and Others), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2026
Esticast Research and Consulting offers the latest published report on Global Oncolytic Virus Therapy Market Analysis and Forecast from 2019 to 2026 delivering key insights and providing a competitive advantage to clients through a detailed report. Additionally, the report focuses on Oncolytic Virus Therapy industry key players, to define and analyze the sales volume, value, market share, market competitive landscape, and recent developments.
Global Oncolytic Virus Therapy market is estimated to reach $138.29 million in 2019 with a CAGR of 26.3% from 2019 to 2026.
About Global Oncolytic Virus Therapy Market
Firstly, the report offers a basic overview of the industry including, definitions, classifications, applications, and industry chain scenario. The Oncolytic Virus Therapy industry analysis is provided for the global market including development history, segment analysis, major regional developments, and a thorough competitor's evaluation.
Secondly, growth policies and plans are reviewed as well as manufacturing processes and cost structures. This report also discusses supply and consumption figures, import/export data, cost, price, revenue and gross margins by prime regions such as the U.S. Europe, China, and Japan along with other key regions. Moreover, Global Oncolytic Virus Therapy Market proposes market trend analysis, drivers, and challenges by consumer behavior, and various marketing channels.
Competitive Glimpse
Top listed manufacturers for Global Global Oncolytic Virus Therapy Market are:
Amgen
Cell Genesys
Cold Genesys
Crusade Laboratories
Genelux Corporation
Lokon Pharma
Merck
MultiVir
Oncolys BioPharma
Oncolytics Biotech
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Targovax
Transgene SA
TILT Biotherapeutics
Viralytics
Vyriad
With the slowdown in world economic growth, the Oncolytic Virus Therapy industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years.
How has the competitive landscape of this industry been categorized?
The competitive scope of Global Oncolytic Virus Therapy Market spans firms listed above, as per the report.
The report includes substantial information pertaining to the produced goods, company profile, revenue graph, as well as other production patterns.
The research study also presents details with respect to the market share that every company accounts for, as well as gross margins and price prototypes of the products.
Market Segmentation:
Esticast Research offers a crystal clear view of the various sections such as segmental analysis, regional analyst, product portfolios, followed by detailed information about market leaders and their strategies about mergers and acquisitions.
By Type
Newcastle Disease Virus-Based Oncolytic Viruses
Vaccinia Virus-Based Oncolytic Viruses
Vesicular Stomatitis Virus-Based Oncolytic Viruses
Adenoviruses-Based Oncolytic Viruses
HSV-Based Oncolytic Viruses
By Application
Breast Cancer
Ovarian Cancer
Melanoma
Prostate Cancer
Others
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
Asia-Pacific
South America
The Middle East and Africa
Reasons to access this report:
Esticast Research and Consulting report is designed in a method that assists clients to gain a complete knowledge of the complete market scenario and the important sectors.
This report consists of meticulous overview of market dynamics, and thorough research.
Explore further market prospects and identify high potential categories based on comprehensive volume and value analysis
Detail information on competitive landscape, current market trends and evolving technologies that can be useful for the companies which are competing in this market
Gaining knowledge about competitive landscape based on thorough brand share analysis to plan an active market positioning
Table of Content
1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources
3. Oncolytic Virus Therapy Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising prevalence rate of cancer globally
3.3.2. Side effects associated with conventional cancer therapies such as Chemotherapy and radiation therapy
3.3.3. undefined
3.4. Restraints
3.4.1. Cannot destroy resistant cancer cells
3.4.2. Limited replication and spreading
3.4.3. Antiviral immune responses
3.4.4. These therapies are still at its initial stage
3.5. Opportunities
3.5.1. On-going R&D activities to get a perfect cure by these therapies
3.5.2. Numerous government investments and initiatives
3.6. Porter's Five Forces Analysis
3.6.1. Porter's Five Forces Analysis
3.7. Market Share Analysis
4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Newcastle Disease Virus-Based Oncolytic Viruses
4.2.1. Market Size & Forecast
4.3. Vaccinia Virus-Based Oncolytic Viruses
4.3.1. Market Size & Forecast
4.4. Vesicular Stomatitis Virus-Based Oncolytic Viruses
4.4.1. Market Size & Forecast
4.5. Adenoviruses-Based Oncolytic Viruses
4.5.1. Market Size & Forecast
4.6. HSV-Based Oncolytic Viruses
4.6.1. Market Size & Forecast
5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Breast cancer
5.2.1. Market Size & Forecast
5.3. Ovarian cancer
5.3.1. Market Size & Forecast
5.4. Melanoma
5.4.1. Market Size & Forecast
5.5. Prostate cancer
5.5.1. Market Size & Forecast
5.6. Others
5.6.1. Market Size & Forecast
6. Oncolytic Virus Therapy Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Oncolytic Virus Therapy Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Oncolytic Virus Therapy Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Oncolytic Virus Therapy Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Oncolytic Virus Therapy Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Oncolytic Virus Therapy Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast
7. Company Profile
7.1. Biovex
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Biovex Product Category, Application, and Specification
7.1.3. Biovex Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Cell Genesys
7.3. Cold Genesys
7.4. Crusade Laboratories
7.5. Genelux Corporation
7.6. Lokon Pharma
7.7. Merck
7.8. MultiVir
7.9. PsiOxus Therapeutics
7.10. SillaJen Biotherapeutics
7.11. Sorrento Therapeutics
7.12. TILT Biotherapeutics
7.13. Vyriad
Tables and Figures
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets